Evidence map›Paper›PMID 41454003›Full record

ArticleScientific reports2025

Copper immobilized MIL-125-NH

Zeynab Sadati, Heshmatollah Alinezhad, Mahmood Tajbakhsh

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zeynab SadatiFaculty of Chemistry, University of Mazandaran, Babolsar, 47416-13534, Iran.
Heshmatollah AlinezhadFaculty of Chemistry, University of Mazandaran, Babolsar, 47416-13534, Iran. heshmat@umz.ac.ir.
Mahmood TajbakhshFaculty of Chemistry, University of Mazandaran, Babolsar, 47416-13534, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multicomponent reactions (MCRs) offer a significant opportunity for simplicity, efficiency, and sustainability in the development of catalytic protocols for synthesizing medicinally important heterocycles. By minimizing environmental impact through the use of green solvents and recyclable heterogeneous catalysts, researches contribute directly to the principles of green chemistry and sustainable industrial practices. In this article, we present the development of a new multifunctional heterogeneous nanocatalyst, Cu@MIL-125-NH-Ac-Met, which was created by sequentially modifying MIL-125-NH

Indexed as

Click reactionsMetal-organic frameworkNanocatalystPost-synthetic processTetrahydrobenzo[b]pyran

Identifiers

PMID41454003
PMCPMC12830769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.